MindMed Q3 Earnings: Big Improvement, Kicks Off Sleep & Cognitive Study With Dose Low-Dose LSDBenzinga • 11/16/21
MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical PipelinePRNewsWire • 11/15/21
MindMed Teams Up With Sphere Health To Identify Biomarkers Associated With Anxiety & DepressionBenzinga • 10/05/21
MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce LintonPRNewsWire • 09/30/21
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory BoardPRNewsWire • 09/29/21